[Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
D000172:Acromegaly / Q000503:physiopathology*; D000328:Adult; D000368:Aged; D001971:Bromocriptine / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology*; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007037:Hypothyroidism / Q000503:physiopathology*; D008875:Middle Aged; D011388:Prolactin / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage*
D004873:Ergolines; D001971:Bromocriptine; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D013006:Growth Hormone
Vliv bromokryptinu na sekreci růstového hormonu a prolaktinu po podáni hormonu uvolnujícího tyreotropin u nemocných s primární hypotyreózou a u akromegalie.